AI, machine learning and Disease. How a Polymath is pioneering the future of medicine.

Dr. Joseph Geraci shares his early fascination with numbers and mathematics, childhood experiences, mathematical synesthesia, dream revelations, and the development of Netramark and machine learning in cancer research. The conversation delves into the intricacies of language models and machine learning, the challenges of heterogeneity in patient populations, the potential of precision medicine and drug repurposing, advancements in cancer research, and the mechanisms of drug resistance in cancer cells. It provides insights into the role of AI in addressing individuality in medical treatment and the future of oncology. The conversation delves into the interconnectedness of cells in the body and the initiation and progression of cancer, shedding light on the complex molecular machinery involved in these processes.TakeawaysMathematical synesthesiaMachine learning in cancer research Language models and machine learningData sets for patient inputClinical trials and NetramarkPrecision medicine and drug repurposingHeterogeneity in patient populationsAI and self-learningCancer research and drug resistance Cellular interconnectednessCancer initiation and progressionChapters00:00 Introduction and Background05:55 Childhood and Early Experiments13:02 Synesthesia and Dream Revelations42:51 Understanding Language Models and Machine Learning51:18 Precision Medicine and Drug Repurposing59:41 Heterogeneity in Patient Populations01:07:18 Advancements in Cancer Research01:18:36 Cancer Initiation and Progression